Top Medical News

Identifying Those at Risk of Falling in Multiple Sclerosis

March 08, 2021

By Victoria Johnson

Ishu Arpan, PhD, senior research associate at Oregon Health & Science University, discussed her team’s investigations into identifying patients with MS at risk of falling.

Telestroke Capacity Linked to Increased Odds of Reperfusion Treatment, Lower Mortality

March 08, 2021

By Marco Meglio

Increases in reperfusion treatment were the largest in lowest-volume hospitals, among rural residents, and among patients aged 85 years and older.

This Week on NeurologyLive — March 8, 2020

March 08, 2021

By NeurologyLive Staff

Here's what is coming soon to NeurologyLive.

AXO-AAV-GM2 Administered to First Patient in GM2 Gangliosidosis Trial

March 07, 2021

By Matt Hoffman

The 2-stage study is an open-label, 2-stage clinical trial designed to evaluate safety and dose-escalation (stage 1) and safety and efficacy (stage 2) of surgically delivered AXO-AAV-GM2.

Fatigue Severely Impacts Quality of Life, Work Productivity in MS

March 07, 2021

By Marco Meglio

Patients having a relapse, confirmed disability accumulation, or worsening in fatigue had significant negative impact on each of the work productivity and activity impairment measures.

Featured

Coverage of the ACTRIMS Forum 2021 Virtual Meeting

The latest news and research presented in multiple sclerosis and related disorders straight from the virtual conference floor

Episode 30: Cognitive Behavioral Therapy for Insomnia

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Jennifer Martin, PhD.

NeuroVoices: Dylan Rice, on Improving Adherence to MS DMTs

The clinical research coordinator at Massachusetts General Hospital discussed his presentation from ACTRIMS 2021 on electronic pill bottle monitoring to promote MS medication adherence.

NeurologyLive Wants Your Feedback!

We kindly ask you to share 5 minutes of your time with us, in order to help us better craft our content to meet your needs and interests. CLICK HERE to take our first audience survey of 2021 before it ends on March 10.

Latest Videos

Treating Narcolepsy and Excessive Daytime Sleepiness

Updates in the Management of Relapsing Multiple Sclerosis

Treating Epilepsy: Key Takeaways From AES 2020

Evaluating Cancer Drug Lenalidomide in Alzheimer Disease: Marwan Sabbagh, MD

Revisions to ILAE Classification of Seizures and Epilepsies: Solomon Moshe, MD; Elissa Yozawitz, MD

Prescribing DMT in Radiologically Isolated Syndrome: Ilena George, MD

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

ACTRIMS 2021 Post-Conference Expert Perspective: Jeffrey Cohen, MD

The Need to Improve Poststroke Care: Mijail Serruya, MD, PhD

How COViMS Registry Is Clarifying MS COVID-19 Risks: Amber Salter, MPH, PhD

The Economic Burden of SMA Prior to Treatment Approvals: Lisa Belter, MPH

High Rates of MS Relapse after TNFα Inhibitor Discontinuation: Spencer Hutto, MD

The Migraine Patient Journey: Episodic Migraine and CGRP Inhibitors

Most Recent

Multiple Sclerosis Care Professionals Satisfied With Clinical Video Telemedicine Visits

March 06, 2021

Article

Researchers found that the percentage of telemedicine visits increased from 15% to 72.8% during the COVID-19 pandemic.

Mechanical Thrombectomy Efficacious in Distal Medium Vessel Occlusion

March 05, 2021

Article

Researchers found that higher NIHSS scores on admission and a successful first-pass effect were predictors of reaching early neurological improvement.

NeurologyLive Friday 5 — March 5, 2021

March 05, 2021

Article

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 5, 2021.

Advanced Alzheimer Flortaucipir Pattern Associated With Increased Risk of Clinical Progression

March 05, 2021

Article

At 18-month follow-up, 70% of those with an advanced Alzheimer disease pattern had 1 point or more increase in CDR-SB, an event predefined as clinically meaningful deterioration.

Understanding the Momentum in the Autoimmune Encephalitis Research Community

March 05, 2021

Article

The assistant professor of neurology at Mayo Clinic discussed his presented talk at ACTRIMS Forum 2021 on autoimmune encephalitis.

The History of Exercise Interventions to Prevent Alzheimer Disease

March 04, 2021

Article

The duo from Cleveland Clinic discussed the reasons for choosing cycling as part of their newly initiated clinical trial, as well as what has been observed for home-based exercise interventions.

African American Patients With MS Switch to Ocrelizumab Treatment Earlier than Caucasian Patients

March 04, 2021

Article

Researchers also found that patients with progressive MS had longer disease duration before starting DMTs than those with relapsing MS.

Tumor Necrosis Factor Signaling Inhibition Fails to Prevent or Delay Parkinson Disease

March 04, 2021

Article

Genetically-index TNF-TNFR1 signaling blockade predicted reduced risk of Crohn disease and ulcerative colitis, and increased multiple sclerosis risk.

Human Oligodendrocyte Differences Due to Environmental Signals Rather Than Lineage

March 04, 2021

Article

Researchers used single-cell RNA sequencing on adult, pediatric, and infant surgical tissues to study oligodendrocyte types in order to better understand multiple sclerosis.

Pegunigalsidase Alfa Demonstrates Efficacy in Phase 3 Fabry Disease Study

March 03, 2021

Article

Protalix BioTherapeutics intends to report final data on the agent, also known as PRX-102 in the second half of 2021, as well as present those findings at an appropriate medical conference.

Phase 1b Study of Investigational Parkinson Disease Agent YTX-7739 Announced

March 03, 2021

Article

Additionally, the therapy’s developer Yumanity Therapeutics announced the results of a single ascending dose study and enrollment in a multiple ascending dose study.

FDA Accepts NDA for FT218 in Treatment of Narcolepsy Symptoms

March 03, 2021

Article

Avadel’s investigational therapy for excessive daytime sleepiness and cataplexy in narcolepsy has an action date set for October 15, 2021.

Predicting MS Disability With IL-1 Receptor Antagonist Levels: Stephanie Blandford, MSc

March 03, 2021

Video

The PhD candidate at the neuroimmunology laboratory at Memorial University of Newfoundland discussed her team’s investigations into the use of IL-1RA as a biomarker for MS disability.

NeuroVoices: Dylan Rice, on Improving Adherence to MS DMTs

March 03, 2021

Article

The clinical research coordinator at Massachusetts General Hospital discussed his presentation from ACTRIMS 2021 on electronic pill bottle monitoring to promote MS medication adherence.

Risdiplam Efficacious in Infants with Spinal Muscular Atrophy Type 1

March 02, 2021

Article

The FIREFISH clinical trial by PTC Therapeutics is 1 of several studies underway evaluating risdiplam in SMA.

FDA Provides Feedback on NurOwn ALS Therapy, Requests More Data

March 02, 2021

Article

The recommendation stems from recently published topline data which demonstrated a clinically meaningful treatment response compared to placebo but failed to meet statistical significance.

The Kenneth P. Johnson Memorial Lecture and the Clinical Course of MS: Benjamin Segal, MD

March 02, 2021

Video

The chair of the Department of Neurology and the director of the Neuroscience Research Institute at The Ohio State University discussed his lecture at ACTRIMS Forum 2021.

Education is Key to Optimum MS Care & Management

March 02, 2021

Article

June Halper, chief executive officer of the Consortium of Multiple Sclerosis Centers, provides an inside perspective on MS education during MS Awareness Month.

Relivion Noninvasive Neuromodulation System Cleared for Acute Migraine

March 02, 2021

Article

The headset system from Neurolief was approved based on the findings of a clinical trial of 131 patients with migraine who utilized the device in treatment sessions of up to 1 hour.

Expanding Research in Autoimmune Encephalitis: Divyanshu Dubey, MBBS

March 02, 2021

Video

The assistant professor of neurology at Mayo Clinic provided his thoughts on the next steps in understanding autoimmune encephalitis and the direction that research must pivot to.